Skip to content

Clinical evaluation the repairing effects of Skinceuticals CE Ferulic after CO2 fractional lasers for treatment of Chinese atrophic acne scars

Clinical evaluation the repairing effects of Skinceuticals CE Ferulic after CO2 fractional lasers for treatment of Chinese atrophic acne scars

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078214
Enrollment
Unknown
Registered
2023-12-01
Start date
2021-10-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic acne scars

Interventions

Experimental group:Skinceuticals CE Ferulic following CO2 fractional laser

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Chinese women or men; (2) 18-60 years old; (3) Subjects with moderate to severe acne scars; (4) Able to understand and follow the study requirements throughout the study period and comply with the follow-up specified in the study protocol; (5) Subjects voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnancy; (2) Patients who are receiving or plan to receive medical treatment and medical cosmetic operators recently; (3) Recent facial exposure to unprotected direct sunlight or artificial ultraviolet light for = 2 hours; (4) Hypersensitivity to any component of the product submitted for testing; (5) Cosmetic users (excluding lip gloss, lipstick, eye lines, eye shadows); (6) Using other skin care products with similar efficacy or the same category; (7) Participated in any other clinical research project within 30 days before the study; (8) Other conditions that the investigator considers inappropriate for participation in this study.

Design outcomes

Primary

MeasureTime frame
Erythema index change from baseline (1, 3, 7, 14 days post-procedure);Time for erythema resolution and scab formation;

Secondary

MeasureTime frame
Change from baseline in stratum corneum water content (1, 3, 7, 14 days post-procedure);Change from baseline in transepidermal water loss (1, 3, 7, 14 days post-procedure);Changes in sebum content from baseline levels;Changes in melanin index compared to baseline levels;

Countries

China

Contacts

Public ContactWei Zhang

Shanghai Skin Disease Hospital

zw5259@163.com+86 158 1070 0716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026